InflaRx NV (MEX:IFRXN) Cyclically Adjusted FCF per Share: MXN-11.59 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:IFRXN InflaRx NV MEX:IFRXN
35 GF Score
Price MXN22.00
! 2 Warning Signs
View Full Analysis

What is InflaRx NV Cyclically Adjusted FCF per Share?

InflaRx NV MEX:IFRXN 35 Cyclically Adjusted FCF per Share is MXN-11.59 as of Jun. 2026. GuruFocus rates MEX:IFRXN with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

InflaRx NV's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN-0.446. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-11.59 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-11), InflaRx NV's current stock price is MXN22.00. InflaRx NV's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN-11.59. InflaRx NV's Cyclically Adjusted Price-to-FCF of today is .


InflaRx NV  (MEX:IFRXN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


InflaRx NV Cyclically Adjusted FCF per Share Related Terms


InflaRx NV Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Cyclically Adjusted FCF per Share Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -26.36

InflaRx NV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -26.36 -29.76 -11.59

MEX:IFRXN vs VRXA, TTRX, IRD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, InflaRx NV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Cyclically Adjusted Price-to-FCF falls into.


MEX:IFRXN
35GF Score
InflaRx NV MEX:IFRXN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InflaRx NV's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.446/131.3638*131.3638
=-0.446

Current CPI (Jun. 2026) = 131.3638.

InflaRx NV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.000 101.017 0.000
201612 0.000 101.217 0.000
201703 -2.368 101.417 -3.067
201706 -2.182 102.117 -2.807
201709 -2.998 102.717 -3.834
201712 -3.697 102.617 -4.733
201803 -5.498 102.917 -7.018
201806 -5.226 104.017 -6.600
201809 -3.626 104.718 -4.549
201812 -5.662 104.217 -7.137
201903 -7.388 104.217 -9.312
201906 -8.763 105.718 -10.889
201909 -7.015 106.018 -8.692
201912 -12.989 105.818 -16.125
202003 -10.470 105.718 -13.010
202006 -7.655 106.618 -9.432
202009 -8.096 105.818 -10.051
202012 -8.343 105.518 -10.387
202103 -7.507 107.518 -9.172
202106 -4.257 108.486 -5.155
202109 -5.454 109.435 -6.547
202112 -6.142 110.384 -7.309
202203 -6.383 113.968 -7.357
202206 -6.015 115.760 -6.826
202209 -1.430 118.818 -1.581
202212 -2.504 119.345 -2.756
202303 -4.535 122.402 -4.867
202306 -3.647 123.140 -3.891
202309 -1.665 124.195 -1.761
202312 -3.425 123.773 -3.635
202403 -4.560 125.038 -4.791
202406 -4.068 125.882 -4.245
202409 -3.586 126.198 -3.733
202412 -4.407 127.041 -4.557
202503 -4.900 127.779 -5.037
202506 -2.426 128.412 -2.482
202509 -2.901 129.255 -2.948
202512 -1.412 129.361 -1.434
202603 -2.134 131.258 -2.136
202606 -0.446 131.364 -0.446

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-11.59 mean?
InflaRx NV (MEX:IFRXN) has a Cyclically Adjusted FCF per Share of MXN-11.59 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InflaRx NV and its competitors.
Is InflaRx NV's Cyclically Adjusted FCF per Share too high?
InflaRx NV's current Cyclically Adjusted FCF per Share is MXN-11.59. Overall, InflaRx NV has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Cyclically Adjusted FCF per Share compare to VRXA and TTRX?
InflaRx NV's Cyclically Adjusted FCF per Share of MXN-11.59 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on InflaRx NV and its competitors. InflaRx NV's current Cyclically Adjusted FCF per Share is MXN-11.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (MEX:IFRXN) has a current Cyclically Adjusted FCF per Share of MXN-11.59. The current Cyclically Adjusted FCF per Share is MXN-11.59. InflaRx NV's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For InflaRx NV (MEX:IFRXN), the current Cyclically Adjusted FCF per Share is MXN-11.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USAIF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
35GF Score

Get the complete analysis for MEX:IFRXN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN22.00
Price